Aspirin May Reduce Breast Cancer Risk in Women with Diabetes
Studies have shown that diabetes increases breast cancer risk, perhaps due to inflammation caused by high blood glucose levels. Research conducted in 2012, for example, suggests women with diabetes have a 20 percent higher risk for developing breast cancer than women without the condition. Now, a study conducted in Taiwan and published in the Journal of Women’s Health, shows daily aspirin could lower this risk.
The data came from a long-term study involving nearly 150,000 women with diabetes. Over the course of 14 years, the women in the study who took low-dose aspirin (75-165 milligrams of aspirin per day) to reduce heart attack and stroke risk were 18 percent less likely to develop breast cancer than those who did not take aspirin. In women who took higher doses, breast cancer risk was reduced by up to 47 percent.
According to researchers, aspirin therapy must be continued for at least 2 ½ years to have this effect. More studies are needed to confirm the link between aspirin therapy and breast cancer risk in women with diabetes.